Category Archives: Diagnostics

Diagnostic antibodies and antigens for dog/canine infectious and non-infectious disease testing

Dogs are the best friends, and most human keep pets for its ompanionship. Dogs need a proper space, diet and health care for their healthy life. However, sometimes the dogs are affected by the different infectious diseases such as amyloidosis, anaplasmosis, anemia, intestinal infection, canine cyclic thrombocytopenia, canine herpes, canine infectious tracheobronchitis, canine parvovirus infection, […]

Diagnostic antibodies and antigens for multiple animal disease testing

Animal disease outbreaks have been shown to cause major economic losses over the centuries. Several diseases such as walking pneumonia, anaplasmosis, aspergilloma, athlete’s foot, babesiosis, bacteremia, brucellosis, campylobacteriosis, candidemia, candidiasis, cellulitis, cholangitis, cholecystitis, clostridial enterotoxicosis, clostridiosis, colitis, cryptosporidiosis, dermatophytosis, diarrhoea, endocarditis, epizootic hemorrhagic disease, esophagitis, foot and mouth disease, fungal infection of nail, jock itch, […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 14 3 June 2021 This briefing provides an update on previous briefings up to 27 May 2021 Summary There are 5 variants of concern and 9 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of Delta (VOC21APR-02, B.1.617.2). A separate report is published covering our […]

Diagnostic antibodies and antigens for avian disease testing

Infectious diseases continue to threaten the sustainability, productivity and growth of the poultry industry worldwide and some present a risk to public health. Many are also present in wild bird populations, with the potential to spill over into domestic birds. The avian infectious disease cause huge economic loss in poultry production and are of great […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 13 27 May 2021 This briefing provides an update on previous briefings up to 22 May 202 Summary There are 5 variants of concern and 9 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of VOC-21APR02 (B.1.617.2) and information on a new variant under investigation […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 12 22 May 2021 This briefing provides an update on previous briefings up to 13 May 2021 Summary There are 5 variants of concern and 8 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of VOC-21APR02 (B.1.617.2) and information on a new variant under investigation […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 11 13 May 2021 This briefing provides an update on previous briefings up to 7 May 2021 Summary There are 5 variants of concern and 7 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of VOC-21APR02 (B.1.617.2). A separate report is published covering our routine […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 16 18 June 2021 This briefing provides an update on previous briefings up to 11 June 2021 Summary There are 4 current variants of concern and 8 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of Delta (VOC21APR-02, B.1.617.2). A separate report is published covering […]

Investigation of novel SARS-CoV-2 variant

Technical briefing 15 11 June 2021 This briefing provides an update on previous briefings up to 3 June 2021 Summary There are 4 variants of concern and 8 variants under investigation (Table 1). This report has been published to continue to share detailed surveillance of Delta (VOC21APR-02, B.1.617.2). A separate report is published covering our […]

Diagnostic antibodies and antigens for Fibrinogen disorders testing: Fibrinogen (FIB)

Fibrinogen disorders are a set of hereditary or acquired abnormalities in the quantity and/or quality of circulating fibrinogens. The disorders may lead to pathological bleeding and/or blood clotting or the deposition of fibrinogen in the liver, kidneys, or other organs and tissues. These disorders include Congenital afibrinogenemia, Congenital hypofibrinogenemia, Fibrinogen storage disease, Congenital dysfibrinogenemia, Hereditary […]